Baxter International (BAX) Other Non-Current Liabilities (2009 - 2026)
Baxter International (BAX) reported Other Non-Current Liabilities of $1.3 billion for Q1 2026, up 15.15% year-over-year from $1.1 billion in Q1 2025, and little changed quarter-over-quarter from $1.3 billion in Q4 2025.
Baxter International (BAX) Other Non-Current Liabilities (2009 - 2026) Analysis & Trends
Baxter International (BAX) has 18 years of Other Non-Current Liabilities data on file, last reported at $1.3 billion in Q1 2026.
- Other Non-Current Liabilities for Q1 2026 came in at $1.3 billion, up 15.15% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.3 billion (up 15.15% YoY), and the FY2025 annual result was $1.3 billion, up 19.61% from the prior year.
- Other Non-Current Liabilities held at $1.3 billion in Q1 2026 per BAX's latest filing, from $1.3 billion in the prior quarter.
- Over five years, Other Non-Current Liabilities peaked at $2.4 billion in Q1 2022 and troughed at $1.1 billion in Q4 2024.
- A 5-year average of $1.6 billion and a median of $1.6 billion in 2024 frame the typical range for Other Non-Current Liabilities.
- The sharpest annual moves came in 2022 and 2025: Other Non-Current Liabilities soared 48.78% in 2022, then tumbled 32.08% in 2025.
- A 5-year view of Other Non-Current Liabilities shows it stood at $1.8 billion in 2022, then retreated by 24.24% to $1.4 billion in 2023, then declined by 23.14% to $1.1 billion in 2024, then advanced by 19.61% to $1.3 billion in 2025, then gained by 0.39% to $1.3 billion in 2026.
- Business Quant data shows BAX's Other Non-Current Liabilities at $1.3 billion in Q1 2026, $1.3 billion in Q4 2025, and $1.1 billion in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn |
| 10 | Aptargroup | 7.72 Bn | 7.52 Bn | 351.91 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.29 Bn |
| Dec 31, 2025 | 1.29 Bn |
| Sep 30, 2025 | 1.12 Bn |
| Jun 30, 2025 | 1.10 Bn |
| Mar 31, 2025 | 1.12 Bn |
| Dec 31, 2024 | 1.08 Bn |
| Sep 30, 2024 | 1.26 Bn |
| Jun 30, 2024 | 1.60 Bn |
| Mar 31, 2024 | 1.65 Bn |
| Dec 31, 2023 | 1.40 Bn |
| Sep 30, 2023 | 1.78 Bn |
| Jun 30, 2023 | 1.62 Bn |
| Mar 31, 2023 | 1.85 Bn |
| Dec 31, 2022 | 1.85 Bn |
| Sep 30, 2022 | 2.07 Bn |
| Jun 30, 2022 | 2.26 Bn |
| Mar 31, 2022 | 2.43 Bn |
| Dec 31, 2021 | 2.49 Bn |
| Sep 30, 2021 | 1.62 Bn |
| Jun 30, 2021 | 1.62 Bn |